Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong Journal:Cost Effectiveness and Resource Allocation | 2020 | 44 | ||
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong Journal:Cost Effectiveness and Resource Allocation | 2020 | 83 | ||
Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation Journal:Hong Kong Medical Journal | 2017 | 71 |